|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBOOKCENTRAL_on1162203938 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
090731s2010 nyu ob 001 0 eng |
010 |
|
|
|a 2020687473
|
040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d VLY
|d N$T
|d YDXCP
|d E7B
|d DKDLA
|d NLGGC
|d EBLCP
|d AZK
|d MERUC
|d AGLDB
|d MOR
|d PIFAG
|d ZCU
|d U3W
|d OCLCF
|d STF
|d VNS
|d WRM
|d VTS
|d NRAMU
|d ICG
|d VT2
|d AU@
|d WYU
|d REC
|d U3G
|d DKC
|d M8D
|d UX1
|d UKCRE
|d OCLCO
|d AJS
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|d TMA
|d OCLCQ
|
015 |
|
|
|a GBA989784
|2 bnb
|
016 |
7 |
|
|a 101512108
|2 DNLM
|
016 |
7 |
|
|a 015367367
|2 Uk
|
019 |
|
|
|a 699510130
|a 961657456
|a 962652020
|a 988410430
|a 992113754
|a 1037915778
|a 1038639925
|a 1045505141
|a 1055403277
|a 1065698565
|a 1081236838
|a 1153531534
|a 1181909446
|
020 |
|
|
|a 9781612093680
|q (e-Book)
|
020 |
|
|
|a 161209368X
|
020 |
|
|
|z 1607415658
|q (hardcover)
|
020 |
|
|
|z 9781607415657
|q (hardcover)
|
029 |
1 |
|
|a AU@
|b 000048636288
|
029 |
1 |
|
|a AU@
|b 000051409927
|
029 |
1 |
|
|a DEBBG
|b BV043164615
|
029 |
1 |
|
|a DEBBG
|b BV044087912
|
029 |
1 |
|
|a DEBSZ
|b 421650109
|
029 |
1 |
|
|a NZ1
|b 15345985
|
035 |
|
|
|a (OCoLC)1162203938
|z (OCoLC)699510130
|z (OCoLC)961657456
|z (OCoLC)962652020
|z (OCoLC)988410430
|z (OCoLC)992113754
|z (OCoLC)1037915778
|z (OCoLC)1038639925
|z (OCoLC)1045505141
|z (OCoLC)1055403277
|z (OCoLC)1065698565
|z (OCoLC)1081236838
|z (OCoLC)1153531534
|z (OCoLC)1181909446
|
042 |
|
|
|a pcc
|
043 |
|
|
|a n-us---
|
050 |
0 |
0 |
|a RJ560
|
060 |
|
4 |
|a QV 771
|b S1282 2009
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
0 |
|a 615/.190083
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Safety efforts in pediatric drug development /
|c Conor D. Byrne, editor.
|
264 |
|
1 |
|a New York :
|b Nova Science Publishers, Inc.,
|c [2010]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Pharmacology--research, safety testing and regulation series
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO.
|
588 |
0 |
|
|a Print version record; title from PDF title page, viewed (07/20/2020).
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
610 |
1 |
0 |
|a United States.
|t Best Pharmaceuticals for Children Act.
|
610 |
1 |
2 |
|a United States
|t Best Pharmaceuticals for Children Act
|
630 |
0 |
7 |
|a Best Pharmaceuticals for Children Act (United States)
|2 fast
|
650 |
|
0 |
|a Pediatric pharmacology
|z United States.
|
650 |
|
0 |
|a Pediatrics
|z United States
|v Formulae, receipts, prescriptions
|x Safety measures.
|
650 |
|
0 |
|a Drug development
|z United States
|x Safety measures.
|
650 |
|
0 |
|a Children.
|
650 |
1 |
2 |
|a Drug Approval
|
650 |
2 |
2 |
|a Child
|
650 |
2 |
2 |
|a Drug Evaluation
|x standards
|
650 |
2 |
2 |
|a Drug-Related Side Effects and Adverse Reactions
|x prevention & control
|
650 |
2 |
2 |
|a Legislation, Drug
|
651 |
|
2 |
|a United States
|
650 |
|
6 |
|a Pharmacologie pédiatrique
|z États-Unis.
|
650 |
|
6 |
|a Pédiatrie
|z États-Unis
|v Formules et recettes
|x Sécurité
|x Mesures.
|
650 |
|
6 |
|a Médicaments
|x Développement
|z États-Unis
|x Sécurité
|x Mesures.
|
650 |
|
6 |
|a Enfants.
|
650 |
|
7 |
|a children (people by age group)
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Children
|2 fast
|
650 |
|
7 |
|a Pediatric pharmacology
|2 fast
|
650 |
|
7 |
|a Pediatrics
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|
700 |
1 |
|
|a Byrne, Conor D.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Safety efforts in pediatric drug development.
|d New York : Nova Science Publishers, Inc., [2010]
|z 1607415658
|w (DLC) 2009031817
|
830 |
|
0 |
|a Pharmacology-research, safety testing, and regulation series.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3018953
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3018953
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10662759
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 349633
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3620184
|
994 |
|
|
|a 92
|b IZTAP
|